EX-99.82 83 d20922dex9982.htm EX-99.82 EX-99.82

Exhibit 99.82

FORM 13-501F1

CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS –

PARTICIPATION FEE

MANAGEMENT CERTIFICATION

 

I, Lisa Helbling                    , an officer of the reporting issuer noted below have examined this Form 13-501F1 (the Form) being submitted hereunder to the Alberta Securities Commission and certify that to my knowledge, having exercised reasonable diligence, the information provided in the Form is complete and accurate.
   

Lisa Helbling, Chief Financial Officer                        

    August 28, 2020
    

 

Name:

    Date:

Title:

     

 

Reporting Issuer Name:

        ImmunoPrecise Antibodies Ltd.       

End date of previous financial year:

                April 30, 2020               

Type of Reporting Issuer:

   

[x] Class 1 reporting

   

[    ] Class 3B reporting

  

issuer

   

issuer

Highest Trading Marketplace:

                TSX Venture               

Market value of listed or quoted equity securities:

   

Equity Symbol

              IPA             

1st Specified Trading Period (dd/mm/yy)

        05/01/19       to               31/07/19      

Closing price of the security in the class or series on the

  

last trading day of the specified trading period in which

  

such security was listed or quoted on the highest trading

  

$                             0.5900

marketplace

     

(i)

Number of securities in the class or series of such

security outstanding at the end of the last trading day of

                        67,989,445  

the specified trading period

       (ii)                                  
      (i) x (ii)            $            40,113,772.55  

Market value of class or series

       (A)                                  

2nd Specified Trading Period (dd/mm/yy)

               01/08/19             to          31/10/19        

 

Closing price of the security in the class or series on the

last trading day of the specified trading period in which

such security was listed or quoted on the highest trading marketplace

       $                        0.6000  
      (iii)                                  

Number of securities in the class or series of such

security outstanding at the end of the last trading day of

                        67,994,445  
the specified trading period       (iv)                                  
      (iii) x (iv)            $                40,796,667  

Market value of class or series

       (B)                                  

3rd Specified Trading Period (dd/mm/yy)

               01/11/19             to          31/01/20        

 

Closing price of the security in the class or series on the

last trading day of the specified trading period in which

such security was listed or quoted on the highest trading marketplace

       $                        0.5700  
      (v)                                  

Number of securities in the class or series of such

security outstanding at the end of the last trading day of

the specified trading period

                        67,994,445  
      (vi)                                  
      (v) x (vi)            $            38,756,833.65  

Market value of class or series

       (C)                                  

4th Specified Trading Period (dd/mm/yy)

   

        01/02/20          to        30/04/20        

Closing price of the security in the class or series on the

   

last trading day of the specified trading period in which

   

such security was listed or quoted on the highest trading

    $                      0.7700

marketplace

   

(vii)                                 

Number of securities in the class or series of such

   

security outstanding at the end of the last trading day of

                    67,994,445

the specified trading period

   

(viii)                                 

  

(vii) x (viii)             $            52,355,722.65

Market value of class or series

    (D)                                

5th Specified Trading Period (dd/mm/yy)

   

    Not applicable       to                            

Closing price of the security in the class or series on the

   

last trading day of the specified trading period in which

   

such security was listed or quoted on the highest trading

    $                                  

marketplace

   

(ix)                                 

Number of securities in the class or series of such

   

security outstanding at the end of the last trading day of

                                    

the specified trading period

    (x)                                
  

(ix) x (x)            $                                   

Market value of class or series

    (E)                                

Average Market Value of Class or Series (Calculate

   

the simple average of the market value of the class or

   

series of security for each applicable specified trading

    $            43,005,748.96

period (i.e. A through E above))

    (1)                                
(Repeat the above calculation for each other class or series of equity securities of the reporting issuer (and a subsidiary, if applicable) that was listed or quoted on a marketplace at the end of the previous financial year)

Fair value of outstanding debt securities:

     

(Provide details of how value was determined)

      $                                
           (2)  

Capitalization for the previous financial year

      (1 ) + (2)    $      43,005,748.96  

Participation Fee

      $           1,200.0000  

Late Fee, if applicable

      $                                

Total Fee Payable

      $           1,200.0000  

(Participation Fee plus Late Fee)